Delivery Order SPE2DB22D2009-SPE2DB25FL9WR
Award Date
6/25/25
Potential Completion Date
7/17/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGE, a pharmaceutical product, with a ceiling value of $8,440.40 and a performance period extending to June 12, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML syringes, a medical product, with a ceiling value of $14,406.80 and a performance period through July 15, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGE, a pharmaceutical product, with a ceiling value of $1,688.08. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a medical product, with a ceiling value of $4,322.04 and a period of performance ending on July 9, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,440.70 fixed-price contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of July 23, 2025. The contract is not designated as a set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XOLAIR 150 MG/ML SYRINGE. The order is a firm fixed-price contract with a ceiling value of $8,644.08 and a period of performance through July 17, 2025. The contract is not set aside and represents open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XOLAIR 150 MG/ML SYRINGEML. The contract is a firm fixed-price delivery order with a ceiling value of $1,440.70 and a period of performance ending on June 27, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,440.40, is for the supply of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a period of performance extending through May 20, 2025. This award is not associated with a set-aside program and represents open competition. Amerisourcebergen Drug Corp is the prime...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XOLAIR 150 MG/ML SYRINGEML, a medical product, with a ceiling value of $8,644.08 and a performance period ending on July 1, 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGE medical supplies, with a ceiling value of $8,440.40 and a period of performance through June 5, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...